This Week in Cell

A team from New York University, the IBM Thomas J. Watson Research Center, and Columbia University used a combination of deep RNA sequencing and chromatin immunoprecipitation sequencing to look at whether the Notch pathway signaling pathway glitches that have been associated with T cell lymphoblastic leukemia, or T-ALL, impact downstream long non-coding RNA targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.